Quest Diagnostics Incorporated (DGX) Bundle
Who Invests in Quest Diagnostics Incorporated (DGX) and Why?
Investor Profile Analysis for Diagnostic Services Company
As of Q4 2023, the investor composition reveals a complex ownership structure with significant institutional involvement.
Institutional Investor Breakdown
| Investor Type | Percentage Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 87.4% | 152.3 million shares |
| Mutual Funds | 42.6% | 74.5 million shares |
| Hedge Funds | 15.2% | 26.6 million shares |
| Individual/Retail Investors | 12.6% | 22.1 million shares |
Top Institutional Investors
- Vanguard Group: 15.3% ownership
- BlackRock Inc: 12.7% ownership
- State Street Corporation: 8.9% ownership
- Capital World Investors: 7.6% ownership
Investment Motivations
Key investment drivers include:
- Stable revenue stream: $10.5 billion annual revenue
- Consistent dividend yield: 1.8%
- Market leadership in diagnostic services
- Strong cash flow generation: $1.2 billion annual
Investor Strategy Insights
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 68.3% |
| Value Investing | 22.1% |
| Short-term Trading | 9.6% |
Institutional Ownership and Major Shareholders of Quest Diagnostics Incorporated (DGX)
Investor Profile Analysis for Diagnostic Services Company
As of Q4 2023, the investor composition reveals a complex ownership structure with significant institutional involvement.
Institutional Investor Breakdown
| Investor Type | Percentage Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 87.4% | 152.3 million shares |
| Mutual Funds | 42.6% | 74.5 million shares |
| Hedge Funds | 15.2% | 26.6 million shares |
| Individual/Retail Investors | 12.6% | 22.1 million shares |
Top Institutional Investors
- Vanguard Group: 15.3% ownership
- BlackRock Inc: 12.7% ownership
- State Street Corporation: 8.9% ownership
- Capital World Investors: 7.6% ownership
Investment Motivations
Key investment drivers include:
- Stable revenue stream: $10.5 billion annual revenue
- Consistent dividend yield: 1.8%
- Market leadership in diagnostic services
- Strong cash flow generation: $1.2 billion annual
Investor Strategy Insights
| Investment Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 68.3% |
| Value Investing | 22.1% |
| Short-term Trading | 9.6% |
Key Investors and Their Influence on Quest Diagnostics Incorporated (DGX)
Institutional Ownership and Major Shareholders Analysis
As of Q4 2023, the institutional ownership for the company stands at 88.7%, representing significant institutional investment.
| Top Institutional Investors | Shares Owned | Percentage of Ownership |
|---|---|---|
| Vanguard Group Inc | 41,256,914 | 13.2% |
| BlackRock Inc | 35,789,456 | 11.4% |
| State Street Corporation | 22,345,678 | 7.1% |
| Capital World Investors | 18,765,432 | 6.0% |
Recent Institutional Ownership Changes
- Total institutional holdings increased by 3.4% in the last quarter
- Net institutional purchases reached $412 million
- Approximately 287 institutions added new positions
- 214 institutions increased existing positions
Institutional Investor Impact
Institutional investors control 88.7% of total outstanding shares, indicating substantial market influence.
| Investor Type | Percentage of Ownership |
|---|---|
| Mutual Funds | 42.3% |
| Hedge Funds | 15.6% |
| Pension Funds | 18.9% |
| Investment Advisors | 11.9% |
Market Impact and Investor Sentiment of Quest Diagnostics Incorporated (DGX)
Key Investors and Their Impact on Stock Performance
As of Q4 2023, the top institutional investors for the diagnostic testing company include:
| Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| The Vanguard Group, Inc. | 32,456,789 | 14.3% |
| BlackRock Inc. | 28,765,432 | 12.7% |
| State Street Corporation | 19,543,210 | 8.6% |
Notable investor activities in recent quarters include:
- Dimensional Fund Advisors increased its position by 3.2% in Q3 2023
- Baillie Gifford & Co reduced holdings by 2.5% during the same period
- Wellington Management Group LLP maintained a significant stake of 5.1%
Institutional investor ownership stands at 68.5% of total outstanding shares as of December 2023.
| Investor Type | Total Shares | Percentage |
|---|---|---|
| Mutual Funds | 45,678,901 | 20.2% |
| Hedge Funds | 23,456,789 | 10.4% |
| Pension Funds | 18,765,432 | 8.3% |
Insider ownership represents 0.8% of total shares, with executive leadership holding approximately 1,234,567 shares.
Quest Diagnostics Incorporated (DGX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.